Search results
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 50 minutes agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And...
Benzinga via Yahoo Finance· 7 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
Yahoo Finance via AOL· 51 minutes agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 12 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 43 minutes ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 14 hours agoNovavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 14 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 7 hours agoNovavax announced a $1.2 billion licensing partnership with French pharmaceutical company Sanofi on...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 15 hours agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel ...